Advertisement
Review| Volume 44, ISSUE 4, P195-200, December 1991

Interrelationships between prostanoids and skin flap survival: A review

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Davies DN
        A world survey of anticoagulation practice in clinical microvascular surgery.
        Br J Plast Surg. 1982; 35: 96-99
        • Pang CY
        • Forrest CD
        • Morris SF
        Pharmacological augmentation of skin flap viability: a hypothesis to mimic the surgical delay phenomenon or a wishful thought.
        Ann Plast Surg. 1989; 22: 293-306
      1. Vargas J R, Radomski M, Moncada S. The use of prostacyclin in the separation from plasma and washing of human platelets. Prostaglandins 23: 929–945.

        • Proctor KG
        • Shatkin Jr, S
        Arachidonic acid metabolites: basic concepts relevant to plastic surgery.
        J Reconstr Microsurg. 1988; 4: 421-426
        • Moncada S
        • Vane JR
        Arachidonic acid metabolites and their interactions between platelets and blood vessel walls.
        N Engl J Med. 1979; 300: 1142-1147
        • Vane JR
        Prostacyclin: a hormone with therapeutical potential.
        J Endocr. 1982; 95: 3P-43P
        • Knight KR
        • Crabb DJMcK
        • Niall M
        • Angus JA
        • Martin TJ
        • O'Brien BMcC
        Pharmacologic modification of blood flow in the rabbit microvasculature with prostacyclin and related drugs.
        Plast Reconstr Surg. 1985; 75: 692-700
        • Smedegard G
        • Hedqvist P
        • Dahlen S
        • Revenase B
        • Hammarstrom S
        • Samuelsson B
        Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey.
        Nature. 1982; 295: 327-329
        • Ford-Hutchinson AW
        Leukotrienes: their formation and role as inflammatory mediators.
        in: 3rd edn. Federation Proceedings. 44. 1985: 25-29
        • May Jr, JW
        • Chait LA
        • O'Brien BMcC
        • Hurley JV
        The no-reflow phenomenon in experimental free flaps.
        Plast Reconstr Surg. 1978; 61: 256-267
        • Angel MF
        • Mellow CG
        • Knight KR
        • O'Brien BMcC
        Secondary ischaemia time in rodents: contrasting complete pedicle interruption to venous obstruction.
        Plast Reconstr Surg. 1990; 85: 789-793
        • Ames III, A
        • Wright RL
        • Kowada M
        • Thurston JM
        • Majno II, G
        The no-reflow phenomenon.
        Am J Pathol. 1968; 52: 437-453
        • Angel MF
        • Ramasastry SS
        • Swartz WM
        • Narayanan K
        • Kuhns DB
        • Basford RE
        • Futrell JW
        The critical relationship between free radicals and degrees of ischemia: evidence for tissue intolerance of marginal perfusion.
        Plast Reconstr Surg. 1988; 81: 233-239
        • Lelcuk S
        • Huval WV
        • Valeri CR
        • Shepro D
        • Hechtman HB
        Inhibition of ischemia-induced thromboxane synthesis in man.
        J Trauma. 1984; 24: 393-396
        • Feng L-T
        • Berger BE
        • Lysz TW
        • Shaw WW
        Vasoactive prostaglandins in the impending no-reflow state: evidence for a primary disturbance on microvascular tone.
        Plast Reconstr Surg. 1988; 81: 755-764
        • Edstrom LE
        • Balkovich M
        • Slotman GJ
        Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition.
        Ann Plast Surg. 1988; 20: 106-111
        • Angel MF
        • Knight KR
        • Mellow CG
        • Morrison WA
        • O'Brien BMcC
        The effect of prior elevation of skin flaps and ischemia on blood thromboxane levels.
        Ann Plast Surg. 1989; 22: 501-504
        • Johnson PC
        Platelet-mediated thrombosis in microvascular surgery: new knowledge and strategies.
        Plast Reconstr Surg. 1990; 86: 359-367
        • Tate RM
        • Morris HG
        • Schroeder WRC
        • Repine JE
        Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline perfused rabbit lungs.
        J Clin Invest. 1984; 74: 608-613
        • Kaufman Jr, RP
        • Klausner JM
        • Anner H
        • Feingold H
        • Kobzik L
        • Valeri R
        • Shepro D
        • Hechtman HB
        Inhibition of thromboxane (Tx) synthesis by free radical scavengers.
        J Trauma. 1988; 28: 458-464
        • Knight KR
        • Mellow CG
        • Abbey PA
        • Angel MF
        • Lepore DA
        • Arnold LI
        • Gray KA
        • O'Brien BMcC
        Interaction between thromboxane and free radical mechanisms in experimental ischaemic rabbit skin flaps.
        Res Exp Med. 1990; 190: 423-433
        • Knight KR
        • Angel MF
        • Lepore DA
        • Abbey PA
        • Arnold LI
        • Gray KA
        • Mellow CG
        • O'Brien BMcC
        Secondary ischaemia in rabbit skin flaps: the roles played by thromboxane and free radicals.
        Clin Sci. 1991; 80: 235-240
        • Leaf A
        Cell swclling. A factor in ischemic tissue injury.
        Circulation. 1973; 48: 455-458
        • Marzella L
        • Jesudass RR
        • Manson PN
        • Myers RAM
        • Bulkley GB
        Functional and structural evaluation of the vasculature of skin flaps after ischemia and reperfusion.
        Plast Reconstr Surg. 1988; 81: 742-750
        • McCord JM
        Oxygen-derived free radicals in postischemic tissue injury.
        N Engl J Med. 1985; 312: 159-163
        • Acland R
        Thrombus formation in microvascular surgery: an experimental study of the effects of surgical trauma.
        Surgery. 1973; 73: 766-771
        • Morrison WA
        • O'Brien BMcC
        • MacLeod AM
        A long-term view of digital replantation.
        Aust NZ J Surg. 1977; 47: 767-773
        • Emerson DJ
        • Sykes PJ
        The effect of prostacyclin on experimental random pattern flaps in the rat.
        Br J Plast Surg. 1981; 34: 264-266
        • Zachary LS
        • Hegeers JP
        • Robson MC
        • Murphy RC
        Combined prostacyclin and thromboxane synthetase inhibitor UK 38, 485 in flap survival.
        Ann Plast Surg. 1986; 17: 112-115
        • Reus WF
        • Murphy RC
        • Heggers JP
        • Robson MC
        • McCauley RL
        Effect of intraarterial prostacyclin on survival of skin flaps in the pig: biphasic response.
        Ann Plast Surg. 1984; 13: 29-33
        • Knight KR
        • Kawabata H
        • Coe SA
        • Angus JA
        • O'Brien BMcC
        • Sakai K
        Prostacyclin and prostanoid modifiers aid ischemic skin floap survival.
        J Surg Res. 1991; 50: 119-123
        • Radegran K
        • Aren C
        • Teger-Nilsson A-C
        Prostacyclin infusion during extracorporeal circulation for coronary bypass.
        J Thorac Cardiovasc Surg. 1982; 83: 205-211
        • Sasaki GH
        • Pang CY
        Experimental evidence for involvement of prostaglandins in viability of acute skin flaps: effects on viability and mode of action.
        Plast Reconstr Surg. 1981; 67: 335-340
        • Morain WD
        • Pettit RJ
        • Rothkopf DM
        • Coombs JW
        Augmentation of surviving flap area by intraarterial vasodilators administered through implantable pumps.
        Ann Plast Surg. 1983; 11: 46-52
        • Suzuki S
        • Isshiki N
        • Ogawa Y
        • Nishimura R
        • Kurokawa M
        Effect of prostaglandin E1 on experimental flaps.
        Ann Plast Surg. 1987; 19: 49-53
        • Lynch TG
        • Hobson RW
        • Barbalinardo JP
        • Kerr JC
        Effect of intravenous and intra-arterial infusions of prostaglandin E1 on canine hind limb blood flow distribution.
        Surgery. 1984; 96: 35-41
        • Silverman DG
        • Broussea DA
        • Norton KJ
        • Clark N
        • Weinberg H
        The effects of a topical PGE2 analogue on global ischemia in rats.
        Plast Reconstr Surg. 1989; 84: 794-799
        • Ekerdt R
        • Luhm HD
        • Opitz D
        Local effects of the prostacyclin analogue iloprost on cutaneous blood supply and oedema formation.
        Biomedica Biochimica Acta. 1988; 47: S52-S55
        • Nishio S
        • Yamada N
        • Endoh T
        • Isogaya M
        • Fukatsu Y
        • Nishimura S
        • Kanai N
        • Umetsu T
        Effect of beraprost sodium on peripheral circulatory disturbances induced by various simuli.
        Arzneimittelforsch. 1989; 39: 1229-1234
        • Murphy RC
        • Lawrence WT
        • Robson MC
        • Heggers JP
        Surgical delay and arachidonic acid metabolites: evidence for an inflammatory mechanism: an experimental study in rats.
        Br J Plast Surg. 1985; 38: 272-277
        • Weinberg H
        • Song Y
        • Douglas B
        Enhancement of blood flow in experimental microvascular free flaps.
        Microsurgery. 1985; 6: 121-124
        • Hauben DJ
        • Zijlstra FJ
        Prostacyclin formation in delayed pig flank flaps.
        Ann Plast Surg. 1984; 13: 304-308
        • Douglas B
        • Weinberg HK
        • Song Y
        • Silverman DG
        Beneficial effects of ibuprofen on experimental microvascular free flaps: pharmacologic alteration of the no-reflow phenomenon.
        Plast Reconstr Surg. 1987; 76: 366-371
        • Hanley SP
        • Cockbill SR
        • Bevan J
        • Heptinstall S
        Differential inhibition by low-dose aspirin of human venous PGI2 synthesis and platelet TXA2 synthesis.
        Lancet. 1981; 1: 969-971
        • Humphrey SJ
        • Zins GR
        The effects of indomethacin on systemic hemodynamics and blood flow in the conscious dog.
        Res Commun Chem Path Pharmacol. 1983; 39: 229-240
        • Calsson I
        • Linde B
        • Wennmalm A
        Arachidonic acid metabolism and regulation of blood flow: effect of indomethacin on cutaneous and subcutaneous reactive hyperaemia in humans.
        Clin Physiol. 1983; 3: 365-373
        • Randall MV
        • Parry J
        • Hawkeswood E
        • Cross PE
        • Dickinson RP
        UK-37,248. A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.
        Thrombosis Res. 1981; 23: 145-162
        • Tyler HM
        • Saxton Capd
        • Parry MJ
        Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase.
        Lancet. 1981; 1: 629-630
        • Blackwell GJ
        • Flower RJ
        • Russell-Smith N
        • Salmon JA
        • Thorogood PB
        • Vane JR
        1-n-butylimidazole: a potent and selective inhibitor of “thromboxane synthetase”.
        Br J Pharmacol. 1978; 64: 435
        • Grimm J
        • Knapp DR
        • Senator D
        • Halushka PV
        Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation.
        Thrombosis Res. 1981; 24: 307-317
        • Parry MJ
        • Randall MJ
        • Hawkeswood E
        • Cross PE
        • Dickinson RP
        Enhanced production of prostacyclin in blood after treatment with selective thromboxane synthetase inhibitor UK-38,485.
        Br J Pharmacol. 1982; 77: 547
        • Fischer S
        • Struppler M
        • Bohlig B
        • Beruntz C
        • Weber W
        • Weber PC
        The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.
        Circulation. 1983; 68: 821-826
        • Feuerstein N
        • Ramwell PW
        OKY-1581, a potential selective thromboxane synthetase inhibitor.
        Eur J Pharmacol. 1981; 69: 533-534
        • Lefer AM
        • Darius H
        A pharmacological approach to thromboxane receptor antagonism.
        in: 3rd edn. Fed Proc. 46. 1987: 144-148
        • Knight KR
        • Collopy PA
        • O'Brien BMcC
        Response of the rabbit cutaneous microcirculation ro prostanoid modifiers as determined by laser Doppler flowmetry.
        Microvasc Res. 1986; 31: 197-202
        • Knight KR
        • Collopy PA
        • Martin TJ
        • O'Brien BMcC
        Regulation of microvascular prostacyclin and thromboxane with inhibitors of arachidonic acid metabolism.
        Prostaglandins. 1987; 33: 445-458
        • Mellow CG
        • Knight KR
        • Angel MF
        • O'Brien BMcC
        Effect of a thromboxane synthetase inhibitor UK-38,485 on the tolerance of skin flaps of primary ischaemia.
        Aust NZ J Surg. 1990; 60: 293-297
        • Mellow CG
        • Knight KR
        • Angel MF
        • O'Brien BMcC
        The effect of thromboxane synthetase inhibition on tolerance of skin flaps to secondary ischemia caused by venous obstruction.
        Plast Reconstr Surg. 1990; 86: 329-334
        • Ono I
        • Ohura T
        • Murazumi M
        • Sakamura R
        • Chiba S
        A study of the effectiveness of a thromboxane synthetase inhibitor (OKY-046) in increasing the survival length of skin flaps.
        Plast Reconstr Surg. 1990; 86: 1164-1173
        • Knight KR
        • Dvir E
        • Kawabata H
        • Coe SA
        • MacLeod AM
        • O'Brien BMcC
        Factors involved in salvaging ischaemic rabbit skin flaps: ATP, free radicals but not thromboxane.
        Br J Plast Surg. 1989; 42: 675-681
        • Kay S
        • Green C
        The effect of a novel thromboxane synthetase inhibitor dazmegrel (UK-38,485) on random pattern skin flaps in the rat.
        Br J Plast Surg. 1986; 39: 361-363
        • Vermylen J
        • Chamone DAF
        • Verstraete M
        Stimulation of prostacyclin release from vessel wall by BAY g6575.
        Lancet. 1979; 1: 518-520
        • Higgs GA
        Effects of antiinflammatory drugs on arachidonic acid metabolism and leukocyte migration.
        in: 3rd edn. Advances in Inflammation Research. Vol 7. Raven Press, New York1984: 223-238
        • Higgs GA
        • Flower RJ
        • Vane JR
        A new approach to anti-inflammatory drugs.
        Biochem Pharmacol. 1979; 28: 1959-1961
        • Moncada S
        • Radomski MW
        • Palmer RMJ
        Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function.
        Biochem Pharmacol. 1988; 37: 2495-2501
        • Dusting G
        • MacDonald PS
        • Higgs EA
        • Moncada S
        The endogenous nitrovasodilator produced by the vascular endothelium.
        Aust NZ J Med. 1989; 19: 493-498
        • Grace GC
        • MacDonald PS
        • Dusting GJ
        Cyclic nucleotide interactions involved in endothelium-dependent dilatation in rat aortic rings.
        Fur J Pharmacol. 1988; 148: 17-24
        • Dusting GJ
        • MacDonald PS
        Prostacyclin and vascular function: implications for hypertension and atherosclerosis.
        Pharmacol Ther. 1990; 48: 323-344
        • Rohrich RJ
        • Cherry GW
        • Spira M
        Enhancement of skin-flap survival using nitroglycerin ointment.
        Plast Reconstr Surg. 1984; 73: 943-948
        • Moncada S
        • Korbut R
        Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
        Lancet. 1978; 1: 1286-1289
        • Chiesa R
        • Vicari A
        • Mari G
        • Galimbert M
        • Di Carlo V
        • Pozza G
        Use of stable prostacyclin analogue ZK36374 to treat severe lower limb ischemia.
        Lancet. 1985; ii: 95-96
        • Yardumian DA
        • Isenberg DA
        • Rustin M
        • Beleher G
        • Snaith ML
        • Dowd PM
        • Machin SJ
        Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue.
        Br J Rheumatol. 1988; 27: 220-226
        • Rodemaker M
        • Cooke ED
        • Almond NE
        • Beacham JA
        • Smith RE
        • Mant TG
        • Kirby JD
        Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
        Br Med J. 1989; 298: 561-564
        • Schuler JJ
        • Flanigan P
        • Holcroft JW
        • Ursprung JJ
        • Mohrland JS
        • Pyke J
        Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease.
        J Vasc Surg. 1984; 1: 1260
        • Jones DK
        • Higenbottam TW
        • Wallwork J
        Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin).
        Br Heart J. 1987; 57: 270-278
        • Schror K
        • Ohlendorf R
        • Darius H
        Beneficial effects of a new carbacyclin derivative, ZK 36374 in acute myocardial ischaemia.
        J Pharmacol Exp Therapeut. 1981; 219: 243-249
        • Vane JR
        • Anggard EE
        • Botting RM
        Regulatory functions of the vascular endothelium.
        N Engl J Med. 1990; 323: 27-36
        • Yanagisawa M
        • Kurihara H
        • Kimura S
        • Tomobe Y
        • Kebayashi M
        • Mitsui Y
        • Yazaki Y
        • Goto K
        • Masaki T
        A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
        Nature. 1988; 332: 411-415